FUTU HK Help Center-ALPN.US Tender offer
English
Back
Open Account

ALPN.US Tender offer

ALPINE IMMUNE SCIENCES INC (ALPN.US) is offering to purchase all outstanding shares at a price of USD 65 per Share (the "Purchase Price") to holders in net cash, without interest, and subject to withholding taxes (if any) pursuant to the terms and conditions set forth in this purchase offer and related transfer instructions. Participants must obtain the Offer to purchase, related Letter of Transmittal, Notice of Guaranteed Delivery and Schedule 14D-9, dated 22/04/2024 for complete terms and conditions of the offer. Participants should consult their tax advisor for complete details in reference to withholding taxes.

The terms of the offer are as follows:

Option (1): Take no action [Default option]

Option (2): Tender Shares – USD 65 PER SHARE NET IN CASH (less any applicable withholding taxes)

The deadline to tender shares to the offer will be 10/05/2024@ 16:00 (HONG KONG TIME GMT+8).

In the absence of an election, no action will be taken.

Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.

1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: ALPN.US
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:

Note to applicants:
1. For shareholders holding less than 1 share of ALPN.US, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option (1) if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.